ホーム › 腎臓がん（腎細胞がん） › ワシントン
ワシントンにおける腎臓がん（腎細胞がん）の臨床試験
ワシントン内の拠点で、腎臓がん（腎細胞がん）に関する12件の研究が参加者を募集しています。
ワシントン内の都市
公式研究テキスト（英語）
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
- Swedish Medical Center, Seattle
- Fred Hutchinson Cancer Center, Seattle
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06234605Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Providence Regional Cancer System-Aberdeen, Aberdeen
- PeaceHealth Saint Joseph Medical Center, Bellingham
- Providence Regional Cancer System-Centralia, Centralia
- 他19件
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Valley Medical Center, Renton
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT03866382Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- Fred Hutchinson Cancer Center, Seattle
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/25更新 · NCT04981119Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
- Northwest Medical Specialties, Tacoma
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/24更新 · NCT06047379A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
- Local Institution - 0095, Seattle
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/23更新 · NCT07293351Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
- Virginia Mason Medical Center, Seattle
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/18更新 · NCT05327686Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
- Fred Hutchinson Cancer Center, Seattle
- University Of Washington Medical Center, Seattle
- Northwest Cancer Specialists, P.C., Vancouver
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/17更新 · NCT07227415Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
- Xencor Investigative Site, Seattle
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/03更新 · NCT05433142A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
- Fred Hutch Cancer Center, Seattle
被験者募集中第1/2相
18歳以上 · 全性別 · 2025/09/09更新 · NCT06682793Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
- Valley Medical Center, Renton
- North Star Lodge Cancer Center at Yakima Valley Memorial Hospital, Yakima
被験者募集中第3相
18歳以上 · 全性別 · 2025/09/09更新 · NCT04510597A Study of IBI363 in Subjects with Advanced Solid Malignancies
- Fred Hutchinson Cancer Center, Seattle
被験者募集中第2相
18歳以上 · 全性別 · 2024/12/19更新 · NCT06281678ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。